No overview information available.
No background information available.
用于治疗肿瘤,放射治疗及肿瘤化疗时引起的白细胞减少症以及有机溶剂(如苯)等引起的白细胞减少或贫血,也可用于其他原因引起的白细胞减少或贫血症,有一定的近期疗效。
No associated conditions information available.
Title | Posted | Study ID | Phase | Status | Sponsor |
---|
No clinical trials found for this drug
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
---|
No FDA products found for this drug
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
---|
No EMA products found for this drug
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
---|
No HSA products found for this drug
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
---|---|---|---|---|---|---|---|---|---|
国药准字H32025861 | N/A | N/A | 50mg | Chemical Drug | Approved | 2003/01/29 | Domestic | ||
国药准字H32023289 | 片剂 | N/A | 50mg | Chemical Drug | Approved | 2020/07/09 | Domestic | ||
国药准字H32023771 | 片剂 | N/A | 20mg | Chemical Drug | Approved | 2020/08/17 | Domestic | ||
国药准字H32024292 | 片剂 | N/A | 50mg | Chemical Drug | Approved | 2002/09/13 | Domestic | ||
国药准字H44021005 | 片剂 | N/A | 20mg | Chemical Drug | Approved | 2020/01/07 | Domestic | ||
国药准字H21022047 | 片剂 | N/A | 25mg | Chemical Drug | Approved | 2015/05/30 | Domestic | ||
国药准字H43021442 | 片剂 | N/A | 20mg | Chemical Drug | Approved | 2019/12/12 | Domestic | ||
国药准字H20067854 | 片剂 | N/A | 20mg | Chemical Drug | Approved | 2022/02/08 | Domestic | ||
国药准字H44023967 | 片剂 | N/A | 20mg | Chemical Drug | Approved | 2020/09/02 | Domestic | ||
国药准字H50021226 | 片剂 | N/A | 20mg | Chemical Drug | Approved | 2024/10/17 | Domestic |
Product Name | Registration Code | Company | Category | Sale Type | Reg. Date |
---|
No PPB products found for this drug
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
---|
No TGA products found for this drug